IN VITRO GENERATION OF HUMAN RETINAL GANGLION CELLS VIA DIRECT CONVERSION AND STEM CELL DIFFERENTIATION
Summary:
This paper discusses the development of a novel protocol for retinal ganglion cell (RGC) differentiation from human pluripotent stem cells, and the potential applications of this protocol in the treatment of vision loss and blindness from glaucoma and other forms of optic nerve disease.
Categories
- Eye health: The paper discusses the development of a protocol for retinal ganglion cell differentiation, which could be used in the treatment of diseases such as glaucoma that cause vision loss and blindness.
- Education and learning: The paper provides a detailed explanation of the protocol developed for retinal ganglion cell differentiation, contributing to the body of knowledge in this field.
- Patient recovery and healing: The paper discusses the potential applications of the protocol in the treatment of vision loss and blindness, contributing to patient recovery and healing.
Author(s)
VM Sluch
Publication Year:
2015
Number of Citations:
0
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
Education and learning
- Color appearance models
- Genetic dissection of retinal inputs to brainstem nuclei controlling image stabilization
- The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?
- How to report light exposure in human chronobiology and sleep research experiments
Patient recovery and healing
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Understanding the effects of mild traumatic brain injury on the pupillary light reflex
- Injured adult retinal axons with Pten and Socs3 co-deletion reform active synapses with suprachiasmatic neurons
- The effect of light on critical illness